Found 6 matching trials
Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults PHASE4 This is a multicenter, parallel groups, partially randomized, open-label, b...
Show More Location
Jiangsu Provincial Center for Disease Control and Prevention
Learn More & Join Trial
A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults. PHASE1 This is a phase I, randomized, observer-blinded, placebo-controlled and dos...
Show More Location
Sir Run Run Hospital Nanjing Medical University
Learn More & Join Trial
A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years. PHASE1 This is a phase I, randomized, observer-blinded, placebo-controlled and dos...
Show More Location
Sir Run Run Hosipital Nanjing Medical University
Learn More & Join Trial
The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine NA This study plans to enrol 1000 participants 18 years and above, with ≥10% p...
Show More Location
Zhongnan Hospital of Wuhan University
Learn More & Join Trial
SYS6006 in Combination With Enlonstobart Injection Versus Enlonstobart Injection in Participants With Advanced Solid Tumors PHASE1 This study is a Phase Ib/II clinical study. It includes two stages: Phase I...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More PHASE2 This is a phase 2, randomized, observer-blinded, placebo-controlled clinica...
Show More Location
Hebei Provincial Center For Disease Control and Prevention
Learn More & Join Trial